Our Approach

Konagaya Akihiko, CEO,  professor emeritus

Our project has been adopted by the NEDO project titled “Technology Development Project on Next Generation Artificial Intelligence Evolving with Human Beings (P20006, FY2020 – FY2024)“. We are promoting the “Research and Development of Molecular Robot Co-Creation Environment Using AI and VR” in collaboration with Hokkaido University and Kyoto University (Hokkaido University until 2022).

Molecular robots, like living organisms, are composed of self-assembled biomolecules such as phospholipids, DNA, and proteins, which have “senses” and “intelligence,” and can operate autonomously using chemical energy such as ATP. So far, Dr. Konagaya, the president and director, has participated the following projects promoting research on molecular robots:

“Molecular Robotics” funded by MEXT (representative of the Amoeba group, 2012-2016)

“Molecular Artificial Muscle Project” funded by NEDO (R&D leader, 2016-2019)

“Molecular Artificial Pancreatic Islet Cell Project” funded by Kakenhi (representative, 2017-2019),

“Molecular Robotics Ethics Project” funded by JST (Principal, FY 2016, 2017-2020)

Although molecular robotics research has made great progress in basic research over the past decade, the path to practical application is still far from complete. Therefore, I took the opportunity of leaving the Tokyo Institute of Technology in March 2020 to establish a joint venture, the Molecular Robotics Research Institute. We would like to work on design technology, development technology, application technology, and ethical issues of molecular robots such as VR simulation and real-time predictive control, while collaborating with and receiving support from universities and private companies.

We look forward to your support.

Molecular Robotics Research Institute, Co., Ltd.

Akihiko Konagaya, CEO